Skip to content
10-Q

Quarterly Report

CASTLE BIOSCIENCES, INC. CSTL

0001447362-25-000069

← back to feed
Filed
May 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 24, 2025 28.87M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $8.92M
Long Term Debt Q1 2025 · Dec 31, 2024 $9.75M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $89.69M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $119.71M
Current Liabilities Q1 2025 · Mar 31, 2025 $37.27M
Current Liabilities Q1 2025 · Dec 31, 2024 $49.39M
Total Liabilities Q1 2025 · Mar 31, 2025 $61.41M
Total Liabilities Q1 2025 · Dec 31, 2024 $75.4M
Current Assets Q1 2025 · Mar 31, 2025 $349.39M
Current Assets Q1 2025 · Dec 31, 2024 $360.15M
Total Assets Q1 2025 · Mar 31, 2025 $501.72M
Total Assets Q1 2025 · Dec 31, 2024 $531.24M
Shares Diluted Q1 2025 · Mar 31, 2024 27.49M sh
Capex Q1 2025 · Mar 31, 2024 $9.15M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$6.84M
Stockholders Equity Q1 2025 · Mar 31, 2024 $402.46M
Stockholders Equity Q1 2025 · Dec 31, 2023 $391.27M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.09
Eps Basic Q1 2025 · Mar 31, 2024 −$0.09
Sga Expense Q1 2025 · Mar 31, 2024 $48.5M
Rd Expense Q1 2025 · Mar 31, 2024 $13.81M
Net Income Q1 2025 · Mar 31, 2024 −$2.53M
Operating Income Q1 2025 · Mar 31, 2024 −$5.47M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $13.89M
Revenue Q1 2025 · Mar 31, 2024 $72.97M